- Home
- ATHA vs CETY Comparison
ATHA vs CETY Comparison
Compare ATHA & CETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- CETY
- Stock Information
- Founded
- ATHA 2011
- CETY 1993
- Country
- ATHA United States
- CETY United States
- Employees
- ATHA N/A
- CETY N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- CETY Power Generation
- Sector
- ATHA Health Care
- CETY Utilities
- Exchange
- ATHA Nasdaq
- CETY Nasdaq
- Market Cap
- ATHA 21.0M
- CETY 18.7M
- IPO Year
- ATHA 2020
- CETY N/A
- Fundamental
- Price
- ATHA $0.26
- CETY $0.41
- Analyst Decision
- ATHA Buy
- CETY
- Analyst Count
- ATHA 4
- CETY 0
- Target Price
- ATHA $11.25
- CETY N/A
- AVG Volume (30 Days)
- ATHA 214.5K
- CETY 116.0K
- Earning Date
- ATHA 05-09-2025
- CETY 05-23-2025
- Dividend Yield
- ATHA N/A
- CETY N/A
- EPS Growth
- ATHA N/A
- CETY N/A
- EPS
- ATHA N/A
- CETY N/A
- Revenue
- ATHA N/A
- CETY $2,424,659.00
- Revenue This Year
- ATHA N/A
- CETY N/A
- Revenue Next Year
- ATHA N/A
- CETY N/A
- P/E Ratio
- ATHA N/A
- CETY N/A
- Revenue Growth
- ATHA N/A
- CETY N/A
- 52 Week Low
- ATHA $0.22
- CETY $0.36
- 52 Week High
- ATHA $3.67
- CETY $1.54
- Technical
- Relative Strength Index (RSI)
- ATHA 45.40
- CETY 45.89
- Support Level
- ATHA $0.23
- CETY $0.39
- Resistance Level
- ATHA $0.30
- CETY $0.52
- Average True Range (ATR)
- ATHA 0.03
- CETY 0.06
- MACD
- ATHA 0.00
- CETY 0.01
- Stochastic Oscillator
- ATHA 37.12
- CETY 21.43
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About CETY Clean Energy Technologies Inc.
Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business, as well as continuing to support other emerging growth companies with their Clean-tech technologies. It has four segments: Clean Energy HRS & CETY Europe, CETY HK, CETY Renewables and Electronic Manufacturing. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.